PD-L1/TIGIT bispecific antibody showed survival advantage in animal model
文献类型:期刊论文
作者 | Mu, Songlin1,2; Liang, Zhijuan1,2; Wang, Yongmei1,2; Chu, Wendi1,2; Chen, Yi-Li3,4; Wang, Qi1,2; Wang, Guifeng1,2![]() ![]() |
刊名 | CLINICAL AND TRANSLATIONAL MEDICINE
![]() |
出版日期 | 2022-05-01 |
卷号 | 12期号:5页码:5 |
ISSN号 | 2001-1326 |
DOI | 10.1002/ctm2.754 |
通讯作者 | Wang, Guifeng(gfwang@simm.ac.cn) ; Wang, Chunhe(wangc@simm.ac.cn) |
资助项目 | China National Major Scientific and Technological Special Project[2019ZX09732002-006] ; National Natural Science Foundation of China[81872785] ; National Natural Science Foundation of China[81673347] ; Shanghai Municipal Commission of Science and Technology of China[17431904400] ; Shanghai Municipal Commission of Science and Technology of China[19YF1457400] ; Shanghai Municipal Commission of Science and Technology of China[21S11904500] ; Institutes for Drug Discovery and Development, Chinese Academy of Sciences[CASIMM0120202007] ; Institutes for Drug Discovery and Development, Chinese Academy of Sciences[CASIMM0120202008] ; Major Scientific and Technological Special Project of Zhongshan City[191022172638719] ; Major Scientific and Technological Special Project of Zhongshan City[210205143867019] |
WOS研究方向 | Oncology ; Research & Experimental Medicine |
语种 | 英语 |
WOS记录号 | WOS:000791505100001 |
出版者 | JOHN WILEY & SONS LTD |
源URL | [http://119.78.100.183/handle/2S10ELR8/299298] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Wang, Guifeng; Wang, Chunhe |
作者单位 | 1.Chinese Acad Sci, Biotherapeut Discovery Res Ctr, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing, Peoples R China 3.Dartsbio Pharmaceut Ltd, Zhongshan, Peoples R China 4.Shanghai Mabstone Biotechnol Ltd, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Mu, Songlin,Liang, Zhijuan,Wang, Yongmei,et al. PD-L1/TIGIT bispecific antibody showed survival advantage in animal model[J]. CLINICAL AND TRANSLATIONAL MEDICINE,2022,12(5):5. |
APA | Mu, Songlin.,Liang, Zhijuan.,Wang, Yongmei.,Chu, Wendi.,Chen, Yi-Li.,...&Wang, Chunhe.(2022).PD-L1/TIGIT bispecific antibody showed survival advantage in animal model.CLINICAL AND TRANSLATIONAL MEDICINE,12(5),5. |
MLA | Mu, Songlin,et al."PD-L1/TIGIT bispecific antibody showed survival advantage in animal model".CLINICAL AND TRANSLATIONAL MEDICINE 12.5(2022):5. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。